|
Mean (SD) summary statistics of SF-36 QOL in 10 patients. |
|||||||
| SF-36 Subsets |
Baseline 0 |
wk 3 |
wk 6 |
wk 12 |
3 wk vs. 0 |
6 wk vs. 0 |
12 wk vs. 0 |
|
|
|||||||
| Physical function |
83(15.5) |
96(9.4) |
97.5(4.2) |
98.5(3.3) |
0.070 |
0.016* |
0.023* |
| Role limitation due to physical health |
10(10.7) |
18.1(10.4) |
22.5(7.3) |
21.3(7.9) |
0.133 |
0.016* |
0.063 |
| Role limitation due to emotional problems |
10.8(11.1) |
19.2(7.9) |
20.8(8.1) |
22.5(4.0) |
0.148 |
0.047* |
0.027* |
| Vitality |
38.1(11.2) |
48.1(13.2) |
55.6(16.0) |
50.6(17.8) |
0.035* |
0.037* |
0.111 |
| Mental health |
63.5(17.0) |
64.0(20.1) |
72.0(10.9) |
76.0(6.6) |
0.844 |
0.211 |
0.066 |
| Social functioning |
43.8(8.8) |
52.5(9.9) |
57.5(8.7) |
60.0(7.9) |
0.063 |
0.008* |
0.008* |
| Bodily pain |
45.1(16.1) |
76.0(20.1) |
87.3(8.8) |
88.8(16.5) |
0.006* |
0.002* |
0.004* |
| General health |
47.0(16.0) |
58.0(22.5) |
60.0(16.0) |
61.5(12.3) |
0.234 |
0.061 |
0.086 |
|
SF-36: Short-form 36 *significant: exact Wilcoxon Signed Test P-values | |||||||
Capodice et al. Chinese Medicine 2007 2:1 doi:10.1186/1749-8546-2-1 |
|||||||